Thad Allen Huston's most recent trade in Artiva Biotherapeutics Inc was a trade of 220,000 Common Stock done . Disclosure was reported to the exchange on March 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Artiva Biotherapeutics Inc | Thad Allen Huston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 220,000 | 220,000 | - | 0 | Common Stock |